3Q2023 Financial Summary - En Statement of Comprehensive Income (Consolidated) (Unit : Million Baht) Q3/2022 Q3/2023 Increase (Decrease) %YoY 9M2022 9M2023 Increase (Decrease) %YoYAmount % Amount
3Q2023 Financial Summary - Th รายได้รวม เท่ากับ 10,340.77 ลา้นบาท คิดเปนลดลงรอ้ยละ 8.20 กําไรขันต้น เท่ากับ 881.51 ลา้นบาท คิดเปนลดลงรอ้ยละ 4.20 กําไรสุทธิ เท่ากับ 136.54 ลา้นบาท คิดเปนลดลงรอ้ยละ
at least a. business overview; b. financial information; c. risk factors; d. capitalization and indebtedness statement; and e. credit rating (if any). D. Liens In case of issuing secured debt
Summary Significant Event & Business Overview Operating Highlights in Q3/2024 Q3/23 Q3/24 Change +/(-) 9M/23 9M/24 Change +/(-) (THB million) %YoY %YoY Operating Revenue 338 428 27% 900 1,144 27% Gross
Summary 3 Operating Performance 4 Market Overview by Business 6 ▪ Market Overview of Methyl Ester Business 6 ▪ Market Overview of Fatty Alcohols Business 8 Operating Performance by Business Unit 10 ▪ Methyl
แบบ filing baht bond (free form) ในปจจบัุน (รายละเอียดตามเอกสารแนบ 2) (ขอมูลขั้นต่ําท่ีกําหนดในมาตรา 69 และ70) D. Business overview ม.69 (6) ลักษณะการประกอบธุรกิจ E. Group Structure × F. Patents
required, to list the risk factors in the order of their priority to the issuer. The Risk Factors section is intended to be a summary of more detailed discussion contained elsewhere in the registration
Limited (“the Company”) would like to submit this Management Discussion and Analysis for the year ended 31 December 2018 with details as follows: Summary overview In 2018, the company had loss for the year
been submitted based on separate financial statements only.) Summary overview From the end of 1st quarter of 2020, the epidemic situation of the coronavirus disease 2019 (COVID-19) has negatively
Analysis have been submitted based on separate financial statements only.) Summary overview From the end of 1st quarter of 2020, the epidemic situation of the coronavirus disease 2019 (COVID-19) has